Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and safety of tipepidine as adjunctive therapy in children with attention-deficit/hyperactivity disorder: Randomized, double-blind, placebo-controlled clinical trial.
Dehbozorghi S, Bagheri S, Moradi K, Shokraee K, Mohammadi MR, Akhondzadeh S. Dehbozorghi S, et al. Among authors: bagheri s. Psychiatry Clin Neurosci. 2019 Nov;73(11):690-696. doi: 10.1111/pcn.12913. Epub 2019 Aug 3. Psychiatry Clin Neurosci. 2019. PMID: 31294924 Free article. Clinical Trial.
The First Comprehensive Cohort of the Duchenne Muscular Dystrophy in Iranian Population: Mutation Spectrum of 314 Patients and Identifying Two Novel Nonsense Mutations.
Zamani G, Hosseini Bereshneh A, Azizi Malamiri R, Bagheri S, Moradi K, Ashrafi MR, Tavasoli AR, Mohammadi M, Badv RS, Ghahvechi Akbari M, Heidari M. Zamani G, et al. Among authors: bagheri s. J Mol Neurosci. 2020 Oct;70(10):1565-1573. doi: 10.1007/s12031-020-01594-9. Epub 2020 May 21. J Mol Neurosci. 2020. PMID: 32436198
Resveratrol adjunct to methylphenidate improves symptoms of attention-deficit/hyperactivity disorder: a randomized, double-blinded, placebo-controlled clinical trial.
Rafeiy-Torghabeh M, Ashraf-Ganjouei A, Moradi K, Bagheri S, Mohammadi MR, Akhondzadeh S. Rafeiy-Torghabeh M, et al. Among authors: bagheri s. Eur Child Adolesc Psychiatry. 2021 May;30(5):799-807. doi: 10.1007/s00787-020-01562-z. Epub 2020 May 24. Eur Child Adolesc Psychiatry. 2021. PMID: 32449130 Clinical Trial.
Inhibition of phosphodiesterase IV enzyme improves locomotor and sensory complications of spinal cord injury via altering microglial activity: Introduction of Roflumilast as an alternative therapy.
Moradi K, Golbakhsh M, Haghighi F, Afshari K, Nikbakhsh R, Khavandi MM, Faghani S, Badripour A, Etemadi A, Ashraf-Ganjouei A, Bagheri S, Dehpour AR. Moradi K, et al. Among authors: bagheri s. Int Immunopharmacol. 2020 Sep;86:106743. doi: 10.1016/j.intimp.2020.106743. Epub 2020 Jun 30. Int Immunopharmacol. 2020. PMID: 32619958
[No title available]
[No authors listed] [No authors listed] PMID: 32815851
429 results